These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3286264)

  • 1. Recorded sudden cardiac death: relationship to antiarrhythmic therapy.
    Hohnloser SH; Meinertz T
    Eur Heart J; 1988 Feb; 9 Suppl B():27-31. PubMed ID: 3286264
    [No Abstract]   [Full Text] [Related]  

  • 2. New approaches to drug selection and serial drug testing.
    Somberg JC
    J Clin Pharmacol; 1984 Jul; 24(7):320-7. PubMed ID: 6207209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for antiarrhythmic therapy: a wealth of controversy, a dearth of data.
    Woosley RL
    Ann Intern Med; 1988 Mar; 108(3):450-2. PubMed ID: 3277517
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs.
    Buxton AE; Josephson ME
    Circulation; 1986 Feb; 73(2 Pt 2):II67-72. PubMed ID: 3943175
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology of cardiopulmonary resuscitation.
    Grundler WG; Weil MH; Rackow EC
    Acute Care; 1983-1984; 10(1):2-32. PubMed ID: 6388212
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative evaluation of antiarrhythmic agents.
    Morganroth J
    Drugs; 1985; 29 Suppl 4():14-20. PubMed ID: 2861076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive testing for ventricular arrhythmias.
    Morganroth J
    Postgrad Med; 1988 Mar; 83(4):241-8. PubMed ID: 2451238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variants of arrhythmogenic action of anti-arrhythmia agents identified during choice of therapy by a transesophageal electrophysiological study].
    Rychkov AIu; Shurin MS; Shakhov GG
    Kardiologiia; 1993; 33(1):87-9. PubMed ID: 8035557
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of antiarrhythmic drugs by sudden death trials.
    Fisher LD
    Circulation; 1986 Feb; 73(2 Pt 2):II98-100. PubMed ID: 3510770
    [No Abstract]   [Full Text] [Related]  

  • 10. Paradoxical proarrhythmic phenomena evaluated by non-invasive methods.
    Furlanello F
    Eur Heart J; 1988 Feb; 9 Suppl B():25. PubMed ID: 3371368
    [No Abstract]   [Full Text] [Related]  

  • 11. Indications for antiarrhythmic therapy as prophylaxis against sudden death.
    Peter T; Hamamoto H; Jordon J; Platt M; Mandel W
    Cardiovasc Clin; 1980; 11(1):249-66. PubMed ID: 7002303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arrhythmogenic effects of anti-arrhythmia agents].
    Pfeiffer D; Rostock KJ; Rathgen K; Schirdewan A; Kleiner HJ
    Z Gesamte Inn Med; 1987 Jul; 42(14):390-4. PubMed ID: 3673134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive techniques in the evaluation of the arrhythmogenic effects.
    Rydén L
    Eur Heart J; 1988 Feb; 9 Suppl B():19-23. PubMed ID: 3286263
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of the clinical study of a new anti-arrhythmia preparation allapinin].
    Mazur NA; Ivanova LA; Pavlova TS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):30-3. PubMed ID: 3541962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
    Lanza GA; Tamburi S; Mondello Malvestiti FM; Rebuzzi AG; Lucente M
    Cardiologia; 1988 Jun; 33(6):613-8. PubMed ID: 3139292
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of beta-adrenoreceptor blocking agents on the deslanoside-induced arrhythmia and cardiac arrest in guinea pigs.
    Otorii T
    Jpn Circ J; 1971 Dec; 35(12):1535-40. PubMed ID: 4401761
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiarrhythmic therapy, ventricular premature depolarizations and sudden cardiac death: the tip of the iceberg.
    Cobb LA; Werner JA
    Circulation; 1979 May; 59(5):864-5. PubMed ID: 428097
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiarrhythmic agents may cause sudden death; drug testing urged.
    Montgomery BJ
    JAMA; 1979 Apr; 241(17):1771. PubMed ID: 430738
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of patients at risk for arrhythmic death: role of Holter ECG recording.
    Bigger JT; Coromilas J
    Cardiovasc Clin; 1985; 15(3):131-43. PubMed ID: 2421901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.